Chromosomal clues to the development of prostate tumors

Prostate

Volumn 38, Issue 4, 1999, Pages 303-312

  Brothman, Arthur R ^a   Maxwell, Teresa M ^a   Cui, Jiang ^a   Deubler, Debra A ^a   Zhu, Xiao Lin ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosomes; Molecular cytogenetics; Prostate cancer

Indexed keywords

ARTICLE; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 6Q; CHROMOSOME 7Q; CHROMOSOME 8P; CHROMOSOME MAP; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL CHROMOSOME DELETION; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; X CHROMOSOME; Y CHROMOSOME;

CHROMOSOME ABERRATIONS; HUMANS; KARYOTYPING; MALE; PROSTATIC NEOPLASMS;

EID: 0033104569     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19990301)38:4<303::AID-PROS6>3.0.CO;2-E     Document Type: Article

References (86)

1. Nowell PC. Cytogenetic approaches to human cancer genes. FASEB J 1994;8:408-413.
2. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998 CA Cancer J Clin 1998;48:6-29.
3. Pinkel D, Straume T, Gray J. Cytogenetic analysis using quantitative, high sensitivity, fluorescence in situ hybridization. Proc Natl Acad Sci USA 1986;83:2934-2938.
4. Kallioniemi O-P, Kallioniemi D, Rutovitz D, Sudar D, Rotovitz D, Gray JW, Waldeman F, Pinkel D. Comparative genomic hybridization for molecular Cytogenetic analysis of solid tumors. Science 1992;258:818-821.
5. Speicher MR, Ballard SG, Ward DC. Karyoryping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 1996; 12:368-375.
6. Schrock E, du Manior S, Veldman T, Schoell B, Wienberg J, Ferguson-Smith MA, Ning Y, Ledbetter DH, Bar-Am I, Soenksen D, Garini Y, Ried T. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-497.
7. Peehl DM. Serial culture of adult human prostatic epithelial cells. J Tissue Culture Methods 1985;9:53-60.
8. Brothman AR, Peehl DM, Patel AM, McNeal JE. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 1990;50:3795-3803.
9. Lundgren R, Mandahl N, Heim S, Limon J, Henrikson H, Mitelman F. Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosomes Cancer 1992;4:16-24.
10. Konig JJ, Teubel W, Kamst E, Romijn JC, Schroder FH, Hagemeijer A. Cytogenetic analysis of 39 prostate carcinomas and evaluation of short term culture techniques. Cancer Genet Cytogenet 1998;101:116-122.
11. Webb HD, Hawkins AL, Griffin CA. Cytogenetic abnormalities are frequent in uncultured prostate cancer cells. Cancer Genet Cytogenet 1996;88:126-132.
12. Lichter P, Tang CC, Gall K, Hermanson G, Evans G, Housman D, Ward D. High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 1990;247: 64-69.
13. Deubler DA, Williams BJ, Zhu XL, Steele MR, Rohr LR, Jensen JC, Stephenson RA, Changus JE, Miller GJ, Becich MJ, Brothman AR. Allelic loss detected on chromosomes 8, 10 and 17 by fluorescence in situ hybridization using single-copy P1 probes on isolated nuclei from paraffin-embedded prostate tumors. Am J Pathol 1997;150:841-850.
14. Brothman AR, Peehl DM, Patel AM, MacDonald GR, McNeal JE, Ladaga LE, Schellhammer PF. Cytogenetic evaluation of 20 cultured primary prostatic tumors. Cancer Genet Cytogenet 1991; 55:79-84.
15. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR. Cytogenetics of primary prostate adenocarcinoma: clonality and chromosome instability. Cancer Genet Cytogenet 1992;61:165-173.
16. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H. Cytogenetic survey of 32 cancer of the prostate. Cancer Genet Cytogenet 1993;66:93-99.
17. Bergerheim USR, Kunimi K, Collins VP, Ekman P. Deletion mapping of chromosomes 8, 10 and 16 in human prostate carcinoma. Genes Chromosomes Cancer 1991;3:215-220.
18. Kunimi K, Bergerheim USR, Larsson IL, Ekman P, Collins VP. Allelotyping of human prostatic adenocarcinoma. Genomics 1991;11:530-535.
19. Brothman AR, Williams BJ. Cytogenetic cancer markers: chromosomal markers in cancer diagnosis, prognosis and monitoring. Prostate cancer. Totowa, NJ: Humana Press; 1997. p 223-246.
20. Brothman AR. Cytogenetics studies in prostate cancer: are we making progress? Cancer Genet Cytogenet 1997;95:116-121.
21. Visakorpi T, Kallioniemi AH, Syvanen A-C, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi O-P. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995;55:342-247.
22. Babu VR, Miles BJ, Cerny JC, Weiss L, Van Dyke DL. Cytogenetic study of four cancers of the prostate. Cancer Genet Cytogenet 1990;48:83-87.
23. Pienkos EJ, Meisner LF. Adenocarcinoma of the prostate in a 41-year-old man with XXY karyotype and chronic lymphocytic leukemia: report of a case. J Urol 1991;145:148-140.
24. Atkin NB, Baker MC. Chromosome study of five cancers of the prostate. Hum Genet 1985;70:359-364.
25. Macoska JA, Powell IJ, Sakr W, Lane M-A. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J Urol 1992;147:1142-1146.
26. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Banson PD, Powell IJ, Pontes JE. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994;54:3824-3830.
27. Limon J, Dal Cin P, Sandberg AA. Cytogenetic findings in a primary leiomyosarcoma of the prostate. Cancer Genet Cytogenet 1986;22:159-167.
28. Brown JA, Alcaraz A, Takahashi S, Persons D, Lieber MM, Jenkins RB. Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. J Urol 1994;152:1157-1162.
29. Breitkreuz T, Romanakis K, Lutz S, Seitz G, Bonkhoff H, Unteregger G, Zwergel T, Zang KD, Wullich B. Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Res 1993;53:4035-4040.
30. Bova GS, Carter BS, Vussemakers JG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB. Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993;53: 3869-3873.
31. Bova GS, MacGrogan D, Levy A, Pin SS, Bookstein R, Isaacs WB. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer. Genomics 1996;35:46-54.
32. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Biebold J, Lohrs U. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res 1994;54: 4472-4480.
33. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenback AC, Chung LWK, Liang JC. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer 1994;9:19-27.
34. Alcaraz A, Takahashi S, Brown JA, Herath JF, Bergstralh EJ, Larson-kelle JJ, Lieber MM, Jenkins RB. Aneuploidy and aneusomy of chromosome 7 detected by fluorescence in situ hybridization are markers of poor prognosis in prostate cancer. Cancer Res 1994;54:3998-4002.
35. Alers JC, Kritjenburg J, Vissers KJ, Bosman FT, van der Kwast TH, van Dekken H. Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions: analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias. Genes Chromosomes Cancer 1995;12:241-350.
36. Alers JC, Kritenburg PJ, Rosenberg C, Hop WC, Verkerk AM, Schroder FH, van der Swast TH, Bosman FT, van Dekken H. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone. Lab Invest 1997;77:437-448.
37. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R, Vihko P. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res 1997;16:3356-3359.
38. Kawana Y, Komiya A, Takeshi U, Nihei N, Kuramochi H, Suzuki H, Yatani R, Imai T, Don JT, Imai T, Yoshie O, Barrett JC, Isaacs JT, Shimazaki J, Ito H, Ichikawa T. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer. Prostate 1997;32:205-213.
39. Carter BS, Weing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB. Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990;87:8751-8755.
40. Cher ML, Ito T, Weidner N, Carroll PT, Jensen RH. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 1995;153:249-154.
41. Cher ML, Bova GS, Moore DH, Small E, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996;56:3091-3102.
42. Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ. Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res 1996;56:1142-1145.
43. Cooney KA, Wetzel JC, Consolino CM, Wojno KJ. Identification and characterization of proximal 6q deletions in prostate cancer. Cancer Res1996;56:4150-4153.
44. Cui J, Deubler DA, Rohr LR, Zhu XL, Maxwell TM, Changus JE, Brothman AR. Chromosome 7 abnormalities in prostate cancer detected by dual color FISH. Cancer Genet Cytogenet 1998; 197:51-60.
45. Brewster SF, Browne S, Brown KW. Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostate cancer. J Urol 1994;151:1073-1077. +
46. Latil A, Fournier G, Cussenot O, Lidereau R. Differential chromosome allelic imbalance in the progression of human prostate cancer. J Urol 1996;156:1079-1083
47. Godfrey TE, Cher ML, Chhabra V, Jensen R. Allelic imbalance mapping of chromosome 16 shows two regions of common deletion in prostate adenocarcinoma. Cancer Genet Cytogenet 1997;99:36-42.
48. Gao X, Zacharek A, Grignon DJ, Sakr W, Powell IJ, Porter AT, Honn KV. Localization of potential tumor suppressor loci to a <2Mb region on chromosome 17q in human prostate cancer. Oncogene 1995;11:1241-1247.
49. Gao X, Zacharek A, Grignon D, Liu H, Sakr W, Porter AT, Chen YQ, Honn K. High frequency of loss of expression and allelic deletion of the APC and MCC genes in human prostate cancer. Int J Oncol 1995;6:111-117.
50. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 1995; 53:2723-2727.
51. Grubek BM, Kollmorgen TA, Qian JD, Souza-Gburek SM, Lieber MM, Jenkins RB. Chromosomal anomalies in stage D1 prostate adenocarcinoma primary tumors and lymph node metastases detected by fluorescence in situ hybridization. J Urol 1997;157: 223-227.
52. Jenkins RB, Qian J, Lee HK, Huang H, Hirasawa K, Bostwick DG, Proffitt J, Wilber K, Lieber MM, Liu W, Smith D1. A molecular cytogenetic analysis of 7q31 in prostate cancer. Cancer Res 1998;58:759-766.
53. Joos S, Bergerheim USR, Pan Y, Matsuyama H, Bents M, du Manoir S, Lichter P. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 1995;14:267-276.
54. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions. Cancer Res 1997;57: 1058-1062.
55. Konig JJ, Teubel W, Romijn JC, Schroder FH, Hagemeijer A. Gain and loss of chromosomes 1, 7, 8, 18, and Y in 46 prostate cancers. Hum Pathol 1996;27:720-727.
56. Konig JJ, Teubel W, van Dongen WJ, Romijn JC, Hagemeijer A, Schroder FH. Loss and gain of chromosome 1, 18, and Y in prostate cancer. Prostate 1994;25:281-291.
57. Komiya A, Suzuki H, Ueda T, Yatani R, Emi M, Ito H, Shimazaki J. Allelic losses at loci on chromosome 10 are associated with metastasis and progression of human prostate cancer. Genes Chromosomes Cancer 1996;17:245-253.
58. Micale MA, Sanford JS, Powell IJ, Sakr WA, Wolman SR. Defining the extent and nature of cytogenetic events in prostatic adenocarcinoma: paraffin FISH vs. metaphase analysis. Cancer Genet Cytogenet 1993;69:7-12.
59. Qian J, Bostwick DG, Takahashi S, Borell TJ, Herath JF, Lieber MM, Jenkins RB. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res 1995;55:5408-5414.
60. Suzuki H, Komiya A, Emi M, Kuamochi H, Shiraishi T, Yatani R, Shimazaki J. Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 1996;17:225-233.
61. Takahashi S, Qian J, Brown JA, Alcaraz A, Bostwick DG, Lieber MM, Jenkins RB. Potential markers of prostate cancer aggressiveness detected by fluorescence in situ hybridization in needle biopsies. Cancer Res 1994;54:3574-3579.
62. Takahashi S, Shan AL, Ritland SR, Delacey KA, Bostwick DG, Lieber MM, Thibodeau SN, Jenkins RB. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. Cancer Res 1995;55: 4114-4119.
63. Zitzelberger H, Szucs S, Robens E, Weier H-U, Hofler H, Bauchinger M. Combined cytogenetic and molecular genetic analyses of fifty-nine untreated human prostate carcinomas. Cancer Genet Cytogenet 1996;90:37-44.
64. Williams BJ, Jones E, Kozlowski JM, Vessella R, Brothman AR. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Genes Chromosomes Cancer 1997;18:299-304.
65. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte WN, Sawyers CL. Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 1997;3:402-408.
66. Dahiya R, McCarville J, Lee C, Hu W, Kaur G, Carroll P, Deng G. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Int J Cancer 1997;72:283-288.
67. Dahiya R, McCarville J, Hu W, Lee C, Chui RM, Kaur G, Deng G. Chromosome 3p24-26 and 3p22-12 loss in human prostate adenocarcinoma. Int J Cancer 1997;71:20-25.
68. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB, Prochownik EV. Mutation of the MXI1 gene in prostate cancer. Nat Genet 1995;9:249-255.
69. Jenkins RB, Qian J, Lieber MM, Bosrwick DG. Detection of cmyc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997;57:524-531.
70. Williams BJ, Jones E, Zhu XL, Steele MR, Stephenson RA, Rohr LR, Brothman AR. Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer. J Urol 1996;155:720-725.
71. Ittmann MM. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate cancer. Prostate 1996;28:275-281.
72. Jones E, Zhu XL, Rohr LR, Stephenson RA, Brothman AR. Aneusomy of chromosomes 7 and 17 detected by FISH in prostate cancer and the effects of selection in vitro. Genes Chromosomes Cancer 1994;11:173-170.
73. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Banson PD, Powell IJ, Pontes JE. Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res 1994;54:3824-3830.
74. Macoska JA, Powell IJ, Sakr W, Lane M-A. Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. J Urol 1992;147:1142-1146.
75. Brothman AR, Patel AM, Peehl DM, Schellhammer PF. Analysis of prostatic tumor cultures using fluorescence in-situ hybridization (FISH). Cancer Genet Cytogenet 1992;62:180-185.
76. Atkin NB, Baker MC. Chromosome 7q deletions: observations on 13 malignant tumors. Cancer Genet Cytogenet 1993;67:123-125.
77. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line, lnt J Cancer 1978;21:274-281.
78. Lundgren R, Heim S, Mandahl N, Anderson H, Mitelman F. Chromosome abnormalities are associated with unfavorable outcome in prostatic cancer patients. J Urol 1992;147:784-788.
79. Umbas R, Schalken JA, Aulders TW, Carter BS, Karthaus HF, Schaafsma HE, Debruyne FM, Isaacs WB. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;18:5104-5109.
80. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Isola J, Kallioniemi O-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995;9:401-406.
81. Bookstein R, Bova GS, MacGrogan D, Levy A, Isaacs WB. Tumor-suppressor genes in prostatic oncogenesis: a positional approach. Br J Urol [Suppl] 1997;79:28-36.
82. He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EF, Abate-Shen C, Carter KC. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 1997;43:69-77.
83. Inazawa J, Sasaki H, Hagura K, Kakazu N, Abe T, Sasaki T. Precise localization of the human gene encoding cell adhesion kinase beta (CAK beta/PYK2) to chromosome 8 at p21.1 by fluorescence in situ hybridization. Hum Genet 1996;98:508-510.
84. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, Brownstein MJ, Bova GS, Guo H, Bujnovszky P, Nusskern DR, Damber JE, Bergh A, Emanuelsson M, Kallioniemi OP, Walker-Daniels J, Bailery-Wilson JE, Beaty TH, Meyers DA, Walsh PC, Collins FS, Trent JM, Isaacs WB. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371-1374.
85. Sandberg AA. Chromosomal abnormalities in human prostate cancer: their detection and pathological significance. In: Foster CS, Bostswick DG, editors. Pathology of the prostate. Philadelphia: W.B. Saunders Co.; 1998. p 400-427.
86. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res 1997;57:2765-2780.